RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
101880
Wellcome Trust - United Kingdom
WT100183MA
Wellcome Trust - United Kingdom
R01 CA172558
NCI NIH HHS - United States
R01 CA169458
NCI NIH HHS - United States
077012/05/Z
Wellcome Trust - United Kingdom
R01 CA137060
NCI NIH HHS - United States
18131
Cancer Research UK - United Kingdom
088340
Wellcome Trust - United Kingdom
R01 CA157644
NCI NIH HHS - United States
WT088340MA
Wellcome Trust - United Kingdom
093867
Wellcome Trust - United Kingdom
R01 CA139032
NCI NIH HHS - United States
Wellcome Trust - United Kingdom
PubMed
24413735
PubMed Central
PMC3960636
DOI
10.1038/ng.2874
PII: ng.2874
Knihovny.cz E-zdroje
- MeSH
- fúzní onkogenní proteiny genetika MeSH
- genetická variace * MeSH
- genová knihovna MeSH
- genová přestavba genetika MeSH
- homeodoménové proteiny genetika MeSH
- lidé MeSH
- molekulární sekvence - údaje MeSH
- pre-B-buněčná leukemie genetika MeSH
- protein PEBP2A2 genetika MeSH
- regulace genové exprese u nádorů genetika MeSH
- rekombinace genetická genetika MeSH
- represorové proteiny MeSH
- sekvence nukleotidů MeSH
- sekvenční analýza DNA MeSH
- sekvenční delece genetika MeSH
- transkripční faktory bHLH genetika MeSH
- transkripční faktory genetika MeSH
- tumor supresorové geny MeSH
- V(D)J rekombinace genetika MeSH
- variabilita počtu kopií segmentů DNA genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- ATF7IP protein, human MeSH Prohlížeč
- fúzní onkogenní proteiny MeSH
- homeodoménové proteiny MeSH
- MGA protein, human MeSH Prohlížeč
- protein PEBP2A2 MeSH
- RAG-1 protein MeSH Prohlížeč
- represorové proteiny MeSH
- TEL-AML1 fusion protein MeSH Prohlížeč
- transkripční faktory bHLH MeSH
- transkripční faktory MeSH
The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL) cases, is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, characterized by recombination signal sequence motifs near breakpoints, incorporation of non-templated sequence at junctions, ∼30-fold enrichment at promoters and enhancers of genes actively transcribed in B cell development and an unexpectedly high ratio of recurrent to non-recurrent structural variants. Single-cell tracking shows that this mechanism is active throughout leukemic evolution, with evidence of localized clustering and reiterated deletions. Integration of data on point mutations and rearrangements identifies ATF7IP and MGA as two new tumor-suppressor genes in ALL. Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1-positive lymphoblasts, targeting the promoters, enhancers and first exons of genes that normally regulate B cell differentiation.
] Institute for Cancer Research Sutton London UK [2]
Cancer Genome Project Wellcome Trust Sanger Institute Hinxton UK
Centro Ricerca Tettamanti Hospital San Gerardo Monza Italy
Hospital Universitario 12 de Octubre Madrid Spain
Zobrazit více v PubMed
Bhojwani D, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2012;26:265–270. PubMed PMC
Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nature reviews. Cancer. 2003;3:639–649. PubMed
Mori H, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:8242–8247. PubMed PMC
Bateman CM, et al. Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia. Blood. 2010;115:3553–3558. PubMed
Mullighan CG, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758–764. PubMed
Zhang M, Swanson PC. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies. The Journal of biological chemistry. 2008;283:6717–6727. PubMed
Mullighan CG, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008;322:1377–1380. PubMed PMC
Raschke S, Balz V, Efferth T, Schulz WA, Florl AR. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines. Genes, chromosomes & cancer. 2005;42:58–67. PubMed
Waanders E, et al. The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PLoS genetics. 2012;8:e1002533. PubMed PMC
Holmfeldt L, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nature genetics. 2013 PubMed PMC
Hubner S, et al. High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2004;18:84–91. PubMed
Schatz DG, Swanson PC. V(D)J recombination: mechanisms of initiation. Annual review of genetics. 2011;45:167–202. PubMed
Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annual review of immunology. 2000;18:495–527. PubMed
Komori T, Okada A, Stewart V, Alt FW. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science. 1993;261:1171–1175. PubMed
Raghavan SC, Swanson PC, Ma Y, Lieber MR. Double-strand break formation by the RAG complex at the bcl-2 major breakpoint region and at other non-B DNA structures in vitro. Molecular and cellular biology. 2005;25:5904–5919. PubMed PMC
Tsai AG, et al. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell. 2008;135:1130–1142. PubMed PMC
Hesse JE, Lieber MR, Mizuuchi K, Gellert M. V(D)J recombination: a functional definition of the joining signals. Genes & development. 1989;3:1053–1061. PubMed
Mullighan CG, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008;453:110–114. PubMed
Zhang J, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157–163. PubMed PMC
Nik-Zainal S, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979–993. PubMed PMC
Campbell PJ, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 2010;467:1109–1113. PubMed PMC
Baca SC, et al. Punctuated evolution of prostate cancer genomes. Cell. 2013;153:666–677. PubMed PMC
Bailey TL, Williams N, Misleh C, Li WW. MEME: discovering and analyzing DNA and protein sequence motifs. Nucleic acids research. 2006;34:W369–373. PubMed PMC
Stephens PJ, et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature. 2009;462:1005–1010. PubMed PMC
Berger MF, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470:214–220. PubMed PMC
Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74. PubMed PMC
Stephens PJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27–40. PubMed PMC
Shimazaki N, Tsai AG, Lieber MR. H3K4me3 stimulates the V(D)J RAG complex for both nicking and hairpinning in trans in addition to tethering in cis: implications for translocations. Molecular cell. 2009;34:535–544. PubMed PMC
Anderson K, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469:356–361. PubMed
Potter NE, et al. Single cell mutational profiling and clonal phylogeny in cancer. Genome research. 2013 PubMed PMC
Familiades J, et al. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2009;23:1989–1998. PubMed
Kempski H, et al. An investigation of the t(12;21) rearrangement in children with B-precursor acute lymphoblastic leukaemia using cytogenetic and molecular methods. British journal of haematology. 1999;105:684–689. PubMed
van Delft FW, et al. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia. Blood. 2011;117:6247–6254. PubMed
Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. The EMBO journal. 1999;18:7019–7028. PubMed PMC
Cancer Genome Atlas Research N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. The New England journal of medicine. 2013;368:2059–2074. PubMed PMC
Chen S, et al. Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2011;25:1632–1635. PubMed
Jaffe JD, et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nature genetics. 2013;45:1386–1391. PubMed PMC
Harris RS, Petersen-Mahrt SK, Neuberger MS. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Molecular cell. 2002;10:1247–1253. PubMed
Neuberger MS, Rada C. Somatic hypermutation: activation-induced deaminase for C/G followed by polymerase eta for A/T. The Journal of experimental medicine. 2007;204:7–10. PubMed PMC
Alexandrov LB, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415–421. PubMed PMC
Roberts SA, et al. Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Molecular cell. 2012;46:424–435. PubMed PMC
Roberts KG, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer cell. 2012;22:153–166. PubMed PMC
Tsai AG, Lieber MR. RAGs found “not guilty”: cleared by DNA evidence. Blood. 2008;111:1750. PubMed
Boubakour-Azzouz I, Bertrand P, Claes A, Lopez BS, Rougeon F. Terminal deoxynucleotidyl transferase requires KU80 and XRCC4 to promote N-addition at non-V(D)J chromosomal breaks in non-lymphoid cells. Nucleic acids research. 2012;40:8381–8391. PubMed PMC
Hong D, et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science. 2008;319:336–339. PubMed
Tsuzuki S, Seto M, Greaves M, Enver T. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:8443–8448. PubMed PMC
Ross ME, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood. 2003;102:2951–2959. PubMed
Kozarewa I, et al. Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes. Nature methods. 2009;6:291–295. PubMed PMC
Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589–595. PubMed PMC
Varela I, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469:539–542. PubMed PMC
Ye K, Schulz MH, Long Q, Apweiler R, Ning Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics. 2009 PubMed PMC
Van Loo P, et al. Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:16910–16915. PubMed PMC
Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell reports. 2013;3:246–259. PubMed PMC
Greenman C, Wooster R, Futreal PA, Stratton MR, Easton DF. Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics. 2006;173:2187–2198. PubMed PMC
Klipper-Aurbach Y, et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Medical hypotheses. 1995;45:486–490. PubMed
van Dongen JJ, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2003;17:2257–2317. PubMed